Gabelli Healthcare & WellnessRx Trust Declares Fourth Quarter Distribution Of $0.10 Per Share, And Announces Additional Year-End Distribution

The Board of Trustees of The Gabelli Healthcare & Wellness Rx Trust (NYSE: GRX) (the “Fund”) reaffirmed its quarterly distribution policy and declared a $0.10 per share cash distribution payable on December 20, 2012 to common shareholders of record on December 14, 2012.

The Board of Trustees also declared an additional year-end cash distribution in accordance with the minimum distribution requirements for the Internal Revenue Code, which will include any additional income and realized net capital gains in excess of the quarterly distributions for the year. The Board of Trustees has yet to determine the amount of the additional distribution and it will be announced at a later date.

The additional year-end cash distribution will be payable on December 20, 2012 to common shareholders of record on December 14, 2012.

All of the preferred and common share distributions for the year will have the same proportion of net investment income and short and long term capital gains.

The Board of Trustees currently intends to maintain the quarterly distribution level of $0.10 per share. The Board of Trustees believes that this distribution policy is in the best interests of the Fund’s common shareholders. The Board of Trustees recognizes that cash flow may be a consideration for many of the Fund’s shareholders and believes that periodic cash distributions may attract investors seeking cash flow.

Each quarter, the Board of Trustees reviews the amount of any potential distribution from the income, capital gain, or capital available. The Board of Trustees will continue to monitor the Fund’s distribution level, taking into consideration the Fund’s net asset value and the financial market environment. The Fund’s distribution policy and the amount of the quarterly distribution are subject to modification or termination by the Board of Trustees at any time. The distribution rate should not be considered the dividend yield or total return on an investment in the Fund.

If you liked this article you might like

12 Best Biotech and Health Care ETFs to Add to Your Portfolio

Gabelli Healthcare & Wellness's Series A Preferred Shares Cross 5.5% Yield Mark

GRX Ex-Dividend Reminder - 12/10/14

Naughty and Nice Funds, From Best to Worst

Naughty and Nice Funds, From Best to Worst

Checking Up on Biotech

Checking Up on Biotech